Bonus Biogroup Stock Price, News & Analysis
Company Description
Bonus Biogroup (OTC Link: BBIXF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $87.9M.
BBIXF stock has gained 99900.0% over the past year. Shares last traded at $0.1000.
This page provides a comprehensive overview of BBIXF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Bonus Biogroup (BBIXF) stock last traded at $0.1000, up 400.00% from the previous close. Over the past 12 months, the stock has gained 99900.0%. At a market capitalization of $87.9M, BBIXF is classified as a micro-cap stock with approximately 1.2B shares outstanding.
Latest News
Bonus Biogroup has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include covid-19. View all BBIXF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
BBIXF Company Profile & Sector Positioning
Bonus Biogroup (BBIXF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing BBIXF often look at related companies in the same sector, including Biostem Tech (BSEM), Satellos Bioscience Inc (MSCLF), Nuo Therapeutics (AURX), Arch Biopartners (ACHFF), and Helix Biopharma (HBPCF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BBIXF's relative position within its industry.